Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) Short Interest Update

Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) was the recipient of a large decline in short interest in July. As of July 31st, there was short interest totalling 11,290,000 shares, a decline of 12.4% from the July 15th total of 12,890,000 shares. Approximately 4.2% of the company’s stock are short sold. Based on an average trading volume of 2,430,000 shares, the short-interest ratio is currently 4.6 days.

Asensus Surgical Stock Performance

Shares of NYSEAMERICAN ASXC traded up $0.00 during midday trading on Monday, reaching $0.30. 554,869 shares of the company’s stock were exchanged, compared to its average volume of 1,892,458. Asensus Surgical has a 52-week low of $0.17 and a 52-week high of $0.40. The firm has a market cap of $81.70 million, a price-to-earnings ratio of -0.96 and a beta of 1.37.

Asensus Surgical (NYSEAMERICAN:ASXC) last posted its quarterly earnings data on Tuesday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.02). Asensus Surgical had a negative return on equity of 184.10% and a negative net margin of 902.25%. The business had revenue of $2.21 million for the quarter, compared to analysts’ expectations of $1.30 million. As a group, research analysts predict that Asensus Surgical will post -0.24 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, HC Wainwright restated a “neutral” rating and issued a $0.35 target price on shares of Asensus Surgical in a research note on Thursday, May 16th.

Institutional Trading of Asensus Surgical

A hedge fund recently raised its stake in Asensus Surgical stock. Virtu Financial LLC raised its position in shares of Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) by 834.4% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 249,019 shares of the company’s stock after buying an additional 222,368 shares during the quarter. Virtu Financial LLC owned about 0.09% of Asensus Surgical worth $57,000 at the end of the most recent quarter. Institutional investors and hedge funds own 9.35% of the company’s stock.

Asensus Surgical Company Profile

Asensus Surgical, Inc, a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients.